#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myasthenia gravis Hypertriglyceridaemia Anaemia Stevens-Johnson syndrome Progressive multifocal leukoencephalopathy Mucous membrane pemphigoid Sjogren's syndrome Neuroendocrine cell hyperplasia of infancy Chorioretinitis Systemic sclerosis pulmonary Hepatic cirrhosis Neurofibroma Phaeochromocytoma Chronic myelomonocytic leukaemia Cholangitis sclerosing More trials…

    Learn about Rare Diseases

    Pulmonary sarcoidosis – Diagnostics Lennox-Gastaut syndrome – Basic Information Medulloblastoma recurrent – Trials in Disease Gaucher’s disease type I – Life with Disease Ewing’s sarcoma – Diagnostics Marginal zone lymphoma – Life with Disease Medulloblastoma – Diagnostics Congenital nephrogenic diabetes insipidus – Treatment Alagille syndrome – Life with Disease Von Willebrand’s disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LTG-001 Dantrolene Sodium Glucocorticoids Remifentanil LUTETIUM LU-177 HEMOPEXIN, HUMAN Hydrocortisone Avalotcagene Ontaparvovec Etamsylate Dextrose Bp Tetracaine Hydrochloride LIPASE Ecubectedin Melphalan Pentetic Acid PRILOCAINE HYDROCHLORIDE Tislelizumab Ivabradine Hydrochloride Parsaclisib Hydrochloride Ropeginterferon Alfa-2B More therapies…

    Learn about Your Condition

    Colorectal adenoma Aplastic anaemia Pulmonary resection Viral infection Herpes simplex meningitis Erosive oesophagitis Alcoholic liver disease Coma Pancreatic failure Erectile dysfunction Non-obstructive cardiomyopathy Hairy cell leukaemia Oxygen therapy Neurodevelopmental disorder Acute promyelocytic leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cholangitis sclerosing

  • Study on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Simvastatin
    Sweden

  • Study on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Mucous membrane pemphigoid
    • Pemphigus
    • Cholangitis sclerosing
    Investigated Drugs:
    • Aldesleukin
    • Glucose
    Germany

  • Study of Oral Vancomycin for Adults and Young Adults with Primary Sclerosing Cholangitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Vancomycin
    Italy

  • A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

    Recruiting

    3 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Elafibranor
    Austria Belgium Czechia Denmark Finland France +9

  • Study of Fecal Microbiota Transplantation Compared to Sham Treatment for Patients with Primary Sclerosing Cholangitis

    Not yet recruiting

    4 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    • Placebo
    France

  • Study on the Safety and Tolerability of Norucholic Acid Tablets for Patients with Primary Sclerosing Cholangitis (PSC)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cholangitis sclerosing
    Investigated Drugs:
    • Norucholic Acid
    Austria Belgium Denmark France Germany Hungary +4
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!